未登录

S

Samo Guzelj

university of ljubljana

H指数:6

被引数:116

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Probing Immune Signatures of Conjugated Pattern Recognition Receptor Ligands Identifies Chimeras with Potent Adjuvant and Antitumor Activities

探究共轭模式识别受体配体的免疫特征可识别具有强效佐剂和抗肿瘤活性的嵌合体

Journal of Medicinal Chemistry

IF6.8

2026-05-050

OA

Linker Chemistry and Connectivity Fine-Tune the Immune Response and Kinetic Solubility of Conjugated NOD2/TLR7 Agonists

BIOCONJUGATE CHEMISTRY

IF3.9

2024-10-100

OAAI

Distinctive Immune Signatures Driven by Structural Alterations in Desmuramylpeptide NOD2 Agonists

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-09-300

OAAI

Discovery of 2,3-Diaminoindole Derivatives as a Novel Class of NOD Antagonists

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-02-012

PRE

Lipidation of NOD2 Agonists with Adamantane and Stearoyl Moieties Differentially Regulates Their In Vivo Adjuvant Activity

IF5.5

2022-12-092

OAAI

Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2022-11-068

OAAI

Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency

ACS MEDICINAL CHEMISTRY LETTERS

IF4

2022-07-1810

OAAI

Structure-Guided Design of D-Galactal Derivatives with High Affinity and Selectivity for the Galectin-8 N-Terminal Domain

对Galectin-8 N端结构域具有高亲和力和选择性的D-半乳糖衍生物的结构指导设计

ACS MEDICINAL CHEMISTRY LETTERS

IF4

2021-11-028

OAAI

Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2021-05-2717

OAAI

Synthesis of Conformationally Constrained d-Glu-meso-DAP Analogs as Innate Immune Agonists

IF4.6

2020-11-104

OAAI

Structural features and functional activities of benzimidazoles as NOD2 antagonists

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2020-03-0110

PREAI